Biotech Real Estate Slump Has MIT’s Hometown Seeking Backups

Kendall Square, a major biopharmaceutical hub that borders the Massachusetts Institute of Technology’s campus, bills itself ...

What Analysts Are Saying About Ionis Pharmaceuticals Stock

In the assessment of 12-month price targets, analysts unveil insights for Ionis Pharmaceuticals, presenting an average target ...
Life Science Leader

Pharma Direct-To-Patient 2.0: From Experiment To Imperative

Policy pressure, affordability gaps, and consumer expectations are reshaping how pharma companies think about direct to ...

Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Fierce Pharma

‘Like a really promising intern’: Pharma marketers are finding plenty of uses for AI, though concerns remain

AI is now the first place people go to for answers,” according to Jesse Wolfersberger, global lead of I/O Health at Weber ...